Worldwide Antifungal Drugs Market (2018-2022) to Register a CAGR of Over 3% - Astellas Pharma, Basilea Pharmaceutica, Merck and Pfizer are the Dominant Vendors - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 4, 2019--The “Global Antifungal Drugs Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The antifungal drugs market is projected to register a CAGR of over 3% by 2022.
Use of antifungal infections is expected to drive growth in the market
Research has shown synergism between many antifungals, which has led to an increase in clinicians prescribing combination therapies over monotherapies. Also, availability of antifungals with novel mechanisms of actions has promoted the trend of using combinations.
Increase in antifungal research funding
An increase in funding for antifungal research is another key factor contributing to the growth of the global antifungal drugs market. In many European countries, government funding is also available for research in fungal diseases.
Diagnostic challenges due to non-specific symptoms
Antifungals are often associated with mild adverse effects like itching, redness, abdominal pain, and diarrhea.
Key PlayersAstellas Pharma Basilea Pharmaceutica Merck Pfizer
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 05: PIPELINE ANALYSIS
PART 06: MARKET SIZINGMarket definition Market sizing 2017 Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATIONSegmentation by route of administration Comparison by route of administration Topical - Market size and forecast 2017-2022 Oral - Market size and forecast 2017-2022 Parenteral - Market size and forecast 2017-2022 Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPEGeographical segmentation Regional comparison Americas - Market size and forecast 2017-2022 EMEA - Market size and forecast 2017-2022 APAC - Market size and forecast 2017-2022 Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPEOverview Landscape disruption Vendors covered
PART 15: VENDOR ANALYSISMarket positioning of vendors Astellas Pharma Basilea Pharmaceutica Merck Pfizer
For more information about this report visit https://www.researchandmarkets.com/research/6x3cx8/worldwide?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190104005393/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infectious Diseases Drugs
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/04/2019 11:20 AM/DISC: 01/04/2019 11:20 AM